Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113 · cited 1×
“Adiponectin has been found to have many effects in vitro that are compatible with improved insulin signalling and potential protection against atherosclerosi”
BackgroundMaeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Wilson, P. W. F., D’Agostino, R. B., Parise, H., Sullivan, L., & Meigs, J. B. (2005) · Circulation · doi:10.1161/circulationaha.105.539528 · Cited by 2,064
Waist circumference as a measure for indicating need for weight management
Lean, M. E. J., Han, T. S., & Morrison, C. E. (1995) · BMJ · doi:10.1136/bmj.311.6998.158 · Cited by 1,869
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541
Ross, R., Dagnone, D., Jones, P. J. H., Smith, H., Paddags, A., Hudson, R., & Janssen, I. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00008 · Cited by 1,435 · cited 1×
“Furthermore, it would detract from the attention that should be given to weight loss, which has been reported to induce a substantial mobilization of abdominal and visceral adipose tissue among high-risk abdominally obese patient”
BackgroundThe Response to Long-Term Overfeeding in Identical Twins
Bouchard, C., Tremblay, A., Després, J.-P., Nadeau, A., Lupien, P. J., Thériault, G., Dussault, J., Moorjani, S., Pinault, S., & Fournier, G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222101 · Cited by 1,278
Self-citationRegional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Self-citationMetabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
Galassi, A., Reynolds, K., & He, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.031 · Cited by 1,207
Regional adiposity and morbidity.
Kissebah, A. H., & Krakower, G. R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.761 · Cited by 1,130
Metabolic Implications of Body Fat Distribution
Björntorp, P. (1991) · Diabetes Care · doi:10.2337/diacare.14.12.1132 · Cited by 1,046 · cited 1×
“Although excess visceral fat accumulation is associated with various atherogenic and diabetogenic abnormalitie”
BackgroundOrchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948
Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937
Self-citationLaaksonen, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf145 · Cited by 916
Treatment of obesity: need to focus on high risk abdominally obese patients
Després, J.-P., Lemieux, I., & Prud'homme, D. (2001) · BMJ · doi:10.1136/bmj.322.7288.716 · Cited by 826
Self-citationHyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 747
Stern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735 · cited 1×
“largely capture the risk associated with metabolic syndrom”
BackgroundMiyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726 · cited 1×
“In accordance with this hypothesis, treatment with glitazones increases subcutaneous fat depositio”
Zhu, S., Wang, Z., Heshka, S., Heo, M., Faith, M. S., & Heymsfield, S. B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.743 · Cited by 682
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.046 · Cited by 679
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J. K., Shulman, G. I., Castle, A. L., Vinson, C., Eckhaus, M., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7901 · Cited by 676 · cited 1×
“Consistent with this theory is the fact that transgenic mice that are essentially fatless owing to the expression of A-ZIP/F-1 protein — which blocks the activity of several transcription factors — also show liver and muscle insulin resistance and eventually develop diabete”
BackgroundWannamethee, S. G., Shaper, A. G., Lennon, L., & Morris, R. W. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2644 · Cited by 672 · cited 1×
“largely capture the risk associated with metabolic syndrom”
BackgroundResponse of blood lipids to exercise training alone or combined with dietary intervention
LEON, A. S., & SANCHEZ, O. A. (2001) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200106001-00021 · Cited by 662
Is visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651 · cited 1×
“But, for any given amount of total body fat, the subgroup of individuals with a selective excess of intra-abdominal, or visceral, adipose tissue is at substantially higher risk of being characterized by insulin resistance and by the features of metabolic syndrom”
BackgroundSelf-citationVisceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels
Pouliot, M.-C., Després, J.-P., Nadeau, A., Moorjani, S., Prud'Homme, D., Lupien, P. J., Tremblay, A., & Bouchard, C. (1992) · Diabetes · doi:10.2337/diab.41.7.826 · Cited by 635 · cited 1×
“However, metabolic studies conducted exclusively on non-smokers have confirmed the very significant relationship between abdominal adiposity and an atherogenic and diabetogenic metabolic risk profil”
BackgroundSelf-citationMetabolic Syndrome: A Clinical and Molecular Perspective
Moller, D. E., & Kaufman, K. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104751 · Cited by 631
Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity
Lemieux, I., Pascot, A., Prud’homme, D., Alméras, N., Bogaty, P., Nadeau, A., Bergeron, J., & Després, J.-P. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.961 · Cited by 590
Self-citationHavel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575
Relationship between obesity, insulin resistance, and coronary heart disease risk
Abbasi, F., Brown, B. W., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02051-x · Cited by 573 · cited 1×
“Beyond excess body weight Although obesity is a risk factor for insulin resistance and type 2 diabetes, and a significant risk factor for CVD, not every obese patient is insulin resistan”
BackgroundGirman, C. J., Rhodes, T., Mercuri, M., Pyörälä, K., Kjekshus, J., Pedersen, T. R., Beere, P. A., Gotto, A. M., & Clearfield, M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.028 · Cited by 526 · cited 1×
“Conflicting and mostly negative results have been reporte”
ResultThe metabolic syndrome: is this diagnosis necessary?1,2
Reaven, G. M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 524
Stern, M. P., Williams, K., & Haffner, S. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00006 · Cited by 510
Failure of adipocyte differentiation causes type II diabetes mellitus?
Danforth, E. (2000) · Nature Genetics · doi:10.1038/79111 · Cited by 487
Metabolic syndrome: Definition, pathophysiology, and mechanisms
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.013 · Cited by 479
Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam
Klein, B. E. K., Klein, R., & Lee, K. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1790 · Cited by 468
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8456 · Cited by 443 · cited 1×
“Consistent with this theory is the fact that transgenic mice that are essentially fatless owing to the expression of A-ZIP/F-1 protein — which blocks the activity of several transcription factors — also show liver and muscle insulin resistance and eventually develop diabete”
BackgroundTherapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434
Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
Astrup, A., & Finer, N. (2000) · Obesity Reviews · doi:10.1046/j.1467-789x.2000.00013.x · Cited by 428
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427 · cited 1×
“Although there is a debate surrounding the concept of metabolic syndrom”
BackgroundLamarche, B. (1998) · JAMA · doi:10.1001/jama.279.24.1955 · Cited by 417
Studies in the distribution of body fat. III. Effects of cigarette smoking
Shimokata, H. (1989) · JAMA · doi:10.1001/jama.261.8.1169 · Cited by 401 · cited 1×
“Of course, smoking is a confounding factor in the abdominal obesity–insulin resistance association, as smokers have more abdominal adipose tissue than non-smokers even after adjustments for markers of total adiposit”
BackgroundTargeting the Metabolic Syndrome with Exercise: Evidence from the HERITAGE Family Study
KATZMARZYK, P. T., LEON, A. S., WILMORE, J. H., SKINNER, J. S., RAO, D. C., RANKINEN, T., & BOUCHARD, C. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000089337.73244.9b · Cited by 396
Després, J.-P., Couillard, C., Gagnon, J., Bergeron, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1932 · Cited by 386
Self-citationWhy Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome
Bergman, R. N., Kim, S. P., Catalano, K. J., Hsu, I. R., Chiu, J. D., Kabir, M., Hucking, K., & Ader, M. (2006) · Obesity · doi:10.1038/oby.2006.277 · Cited by 371
Abdominal fat distribution and metabolic risk factors: Effects of race
Lovejoy, J. C., de la Bretonne, J. A., Klemperer, M., & Tulley, R. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90011-6 · Cited by 345
Tsimikas, S., Willerson, J. T., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.066 · Cited by 335 · cited 1×
“Plasma levels of C-reactive protein (CRP), an inflammatory marker that is predictive of a risk of myocardial infarction possibly greater than that estimated by traditional risk factor”
BackgroundPoint: Visceral Adiposity Is Causally Related to Insulin Resistance
Lebovitz, H. E., & Banerji, M. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2322 · Cited by 328
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
Grundy, S. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2005 · Cited by 287
Eckel, R. H., Kahn, R., Robertson, R. M., & Rizza, R. A. (2006) · Circulation · doi:10.1161/circulationaha.106.176583 · Cited by 285
Molecular mechanisms of insulin resistance and the role of the adipocyte
Hotamisligil, G. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801497 · Cited by 269
Visceral Fat and Race-Dependent Health Risks in Obese Nondiabetic Premenopausal Women
Albu, J. B., Murphy, L., Frager, D. H., Johnson, J. A., & Pi-Sunyer, F. X. (1997) · Diabetes · doi:10.2337/diab.46.3.456 · Cited by 259 · cited 1×
“Non-Caucasian populations may be more or less prone to abdominal and visceral fat accumulatio”
BackgroundCôté, M., Mauriège, P., Bergeron, J., Alméras, N., Tremblay, A., Lemieux, I., & Després, J.-P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1711 · Cited by 230
Self-citationThe myth of the metabolic syndrome
Gale, E. A. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1873-5 · Cited by 215 · cited 1×
“Although there is a debate surrounding the concept of metabolic syndrom”
BackgroundKadowaki, T., Sekikawa, A., Murata, K., Maegawa, H., Takamiya, T., Okamura, T., El-Saed, A., Miyamatsu, N., Edmundowicz, D., Kita, Y., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803248 · Cited by 215
Kahn, H. S., & Valdez, R. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.5.928 · Cited by 205
Cigarette Smoking and Increased Central Adiposity
Barrett-Connor, E., & Khaw, K.-T. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-10-783 · Cited by 203
Golden, S. H., Folsom, A. R., Coresh, J., Sharrett, A. R., Szklo, M., & Brancati, F. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3069 · Cited by 199
Insulin resistance and compensatory hyperinsulinemia
Reaven, G. M., & Tsao, P. S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02982-0 · Cited by 182
Does a diagnosis of metabolic syndrome have value in clinical practice?1,2
Grundy, S. M. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1248 · Cited by 176
Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model
Jensen, M. D. (2006) · Obesity · doi:10.1038/oby.2006.278 · Cited by 170
Lipodystrophies: rare disorders causing metabolic syndrome
Garg, A., & Misra, A. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.003 · Cited by 147
Extreme Insulin Resistance of the Central Adipose Depot In Vivo
Mittelman, S. D., Van Citters, G. W., Kirkman, E. L., & Bergman, R. N. (2002) · Diabetes · doi:10.2337/diabetes.51.3.755 · Cited by 140 · cited 1×
“Hypertrophied intra-abdominal adipocytes are characterized by a hyperlipolytic state that is resistant to the antilipolytic effect of insuli”
BackgroundDiabetic Macrovascular Disease: The Glucose Paradox?
Libby, P., & Plutzky, J. (2002) · Circulation · doi:10.1161/01.cir.0000037282.92395.ae · Cited by 126
Regional variation in adipose tissue metabolism of severely obese premenopausal women.
Mauriège, P., Marette, A., Atgié, C., Bouchard, C., Thériault, G., Bukowiecki, L. K., Marceau, P., Biron, S., Nadeau, A., & Després, J. P. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40053-7 · Cited by 109
Self-citationLemieux, I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000126485.80373.33 · Cited by 108 · cited 1×
“However, another possibility (which does not exclude a contribution from the two mechanisms described above) is that excess intra-abdominal fat accumulation represents a marker of the relative inability of subcutaneous adipose tissue to act as an 'energy sink' when an individual has to handle a calorie surplus due to…”
BackgroundSelf-citationDevelopment and consequences of insulin resistance: lessons from animals with hyperinsulinaemia.
Shafrir, E. (1996) · PubMed · Cited by 90
Is insulin resistance the cause of the metabolic syndrome?
Ferrannini, E. (2006) · Annals of Medicine · doi:10.1080/07853890500415358 · Cited by 86
Study, T. G. P., Jørgensen, M. E., Glümer, C., Bjerregaard, P., Gyntelberg, F., Jørgensen, T., & Borch‐Johnsen, K. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802434 · Cited by 72
Conway, J., Chanetsa, F. F., & Wang, P. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.6.1345 · Cited by 50
FAMILIAL AGGREGATION OF CARDIOVASCULAR RESPONSE TO SUBMAXIMAL EXERCISE IN THE HERITAGE FAMILY STUDY
LEON, A. S., AN, P., RICE, T., P??russe, L., Gagnon, J., Wilmore, J. H., Skinner, J. S., Rao, D. C., & Bouchard, C. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200105001-01173 · Cited by 43
Waist Girth Does Not Predict Metabolic Complications in Severely Obese Men
Lemieux, I., Drapeau, V., Richard, D., Bergeron, J., Marceau, P., Biron, S., & Mauriège, P. (2006) · Diabetes Care · doi:10.2337/dc06-0441 · Cited by 43 · cited 1×
“However, an increased waistline may be the consequence of excess subcutaneous abdominal adiposity, a situation sometimes observed even in very obese patients with a normal risk-factor profil”
BackgroundSelf-citationMacchia, A., Levantesi, G., Borrelli, G., Franzosi, M. G., Maggioni, A. P., Marfisi, R., Scarano, M., Tavazzi, L., Tognoni, G., Valagussa, F., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.023 · Cited by 37
The metabolic syndrome: should current criteria influence clinical practice?
Sattar, N. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236366.48593.07 · Cited by 34
Dumont, M., Mauriège, P., Bergeron, J., Despres, J., & Prud'homme, D. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801665 · Cited by 24
Self-citationInsulin resistance in human partial lipodystrophy
Hegele, R. A. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0078-0 · Cited by 16 · cited 1×
“, given that there are forms of insulin resistance not related to excess abdominal fa”
BackgroundPaul Zimmet: fighting the “diabesity” pandemic
Pincock, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69682-7 · Cited by 13
Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist.
Underwood, P. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137237.97341.fd · Cited by 10 · cited 1×
“Clinical markers of an altered metabolic risk profile, such as clinical criteria for metabolic syndrome (the simplest being increased triacylglycerol levels), must also be present to suggest the presence of high-risk visceral obesit”
BackgroundAlberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Self-citationThe changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“Such robust evidence has also been previously detailed in several review papers on body fat topography published over the last 20 years (48, 71, 72, 112, 113, 234, 263, 357, 360).”
BackgroundResultInfluentialSelf-citationESPEN guidelines on definitions and terminology of clinical nutrition
Cederholm, T., Barazzoni, R., Austin, P., Ballmer, P., Biolo, G., Bischoff, S. C., Compher, C., Correia, I., Higashiguchi, T., Holst, M., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.004 · Cited by 2,560
“The presence of central obesity (also known as abdominal, visceral, upper-body or android obesity) can be clinically defined by increased waist circumference (WC) measured in the mid-horizontal plane between the superior iliac crest and the lower margin of the last rib [36].”
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.